1) Written informed consent, consistent with ICH-GCP R2 and local laws, obtained before the initiation of any trial related procedure. <br/ >2) Diagnosis of coronavirus (SARS-CoV)-2 infection confirmed by polymerase chain reaction (PCR) test less than 4 days before Visit 1 with signs of an acute respiratory infection. <br/ >3) Age more than equal to 18 and less than equal to 70 years. <br/ >4) CRP more than 50 and less than 150 mg/l. <br/ >5) Admitted to a hospital or controlled facility (home quarantine is not sufficient) <br/ >6) In the opinion of the Investigator, the subject will be able to comply with the requirements of the protocol.

1) Written informed consent, consistent with ICH-GCP R2 and local laws, obtained before the initiation of any trial related procedure. <br/ >2) Diagnosis of coronavirus (SARS-CoV)-2 infection confirmed by polymerase chain reaction (PCR) test less than 4 days before Visit 1 with signs of an acute respiratory infection. <br/ >3) Age more than equal to 18 and less than equal to 70 years. <br/ >4) CRP more than 50 and less than 150 mg/l. <br/ >5) Admitted to a hospital or controlled facility (home quarantine is not sufficient) <br/ >6) In the opinion of the Investigator, the subject will be able to comply with the requirements of the protocol.

1) Written informed consent, consistent with ICH-GCP R2 and local laws, obtained before the initiation of any trial related procedure. <br/ >2) Diagnosis of coronavirus (SARS-CoV)-2 infection confirmed by polymerase chain reaction (PCR) test less than 4 days before Visit 1 with signs of an acute respiratory infection. <br/ >3) Age more than equal to 18 and less than equal to 70 years. <br/ >4) CRP more than 50 and less than 150 mg/l. <br/ >5) Admitted to a hospital or controlled facility (home quarantine is not sufficient) <br/ >6) In the opinion of the Investigator, the subject will be able to comply with the requirements of the protocol.

1) Written informed consent, consistent with ICH-GCP R2 and local laws, obtained before the initiation of any trial related procedure. <br/ >2) Diagnosis of coronavirus (SARS-CoV)-2 infection confirmed by polymerase chain reaction (PCR) test less than 4 days before Visit 1 with signs of an acute respiratory infection. <br/ >3) Age more than equal to 18 and less than equal to 70 years. <br/ >4) CRP more than 50 and less than 150 mg/l. <br/ >5) Admitted to a hospital or controlled facility (home quarantine is not sufficient) <br/ >6) In the opinion of the Investigator, the subject will be able to comply with the requirements of the protocol.